Literature DB >> 23118829

Update in endocrinology - primary hyperaldosteronism - from secondary hypertension towards metabolic syndrome and beyond.

Raluca-Alexandra Trifanescu1, Catalina Poiana.   

Abstract

Entities:  

Year:  2012        PMID： 23118829      PMCID： PMC3484806     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN： 1841-9038


× No keyword cloud information.
  9 in total

1.  Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.

Authors:  Elena A B Azizan; Meena Murthy; Michael Stowasser; Richard Gordon; Bartosz Kowalski; Shengxin Xu; Morris J Brown; Kevin M O'Shaughnessy
Journal:  Hypertension       Date:  2012-01-17       Impact factor: 10.190

2.  Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Tanja Grammer; Christiane Drechsler; Bernhard O Boehm; Winfried März
Journal:  Am J Kidney Dis       Date:  2010-12-24       Impact factor: 8.860

3.  Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism.

Authors:  A Di Murro; L Petramala; D Cotesta; L Zinnamosca; E Crescenzi; C Marinelli; M Saponara; C Letizia
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2010-05-20       Impact factor: 1.636

4.  Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism.

Authors:  J J Mukherjee; C M Khoo; A C Thai; S B Chionh; Lim Pin; K O Lee
Journal:  Diab Vasc Dis Res       Date:  2009-10-28       Impact factor: 3.291

Review 5.  Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

Authors:  Adam Whaley-Connell; Megan S Johnson; James R Sowers
Journal:  Prog Cardiovasc Dis       Date:  2010 Mar-Apr       Impact factor: 8.194

Review 6.  The genetic basis of primary aldosteronism.

Authors:  John W Funder
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

7.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

8.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Authors:  E Born-Frontsberg; M Reincke; L C Rump; S Hahner; S Diederich; R Lorenz; B Allolio; J Seufert; C Schirpenbach; F Beuschlein; M Bidlingmaier; S Endres; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

9.  Changes in the perceived epidemiology of primary hyperaldosteronism.

Authors:  Riccardo Maria Fagugli; Chiara Taglioni
Journal:  Int J Hypertens       Date:  2011-08-04       Impact factor: 2.420
  9 in total
  1 in total

1.  Screening for secondary endocrine hypertension in young patients.

Authors:  Raluca Trifanescu; Mara Carsote; Andra Caragheorgheopol; Dan Hortopan; Anda Dumitrascu; Mariana Dobrescu; Catalina Poiana
Journal:  Maedica (Buchar)       Date:  2013-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.